Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin

Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin

2-Hydroxypropyl-beta-cyclodextrin (HPBCD) is utilized in the formulation of pharmaceutical products and recently orphan designation was granted for the treatment of Niemann−Pick disease, type C. The exact mechanism of HPBCD action and side effects are not completely explained. We used fluo...

Full description

Bibliographic Details
Main Authors: Judit Váradi, Anca Hermenean, Rudolf Gesztelyi, Viktória Jeney, Enikő Balogh, László Majoros, Milo Malanga, Éva Fenyvesi, Lajos Szente, Ildikó Bácskay, Miklós Vecsernyés, Pálma Fehér, Zoltán Ujhelyi, Gábor Vasvári, István Árvai, Ágnes Rusznyák, Cornel Balta, Hildegard Herman, Ferenc Fenyvesi
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Biomolecules
Subjects:
hydroxypropyl-beta-cyclodextrin
pharmacokinetics
HUVECs
endocytosis
fluorescence
Online Access:https://www.mdpi.com/2218-273X/9/10/509

Internet

https://www.mdpi.com/2218-273X/9/10/509

Similar Items